I think there in lies the reason for the push to sell to KIT.Without the bond facility they would only have had $321,000 on hand at end for quarter and at current cash burn rates....
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025